AAP
ANIX icon

Arax Advisory Partners’s Anixa Biosciences ANIX Stock Holding History

Arax Advisory Partners’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280 Buy
+100
New +$278 ﹤0.01% 5064

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Arax Advisory Partners's ANIX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Anixa Biosciences (ANIX) in Q2 2026: 100 shares worth $280. The stake represents ﹤0.01% of the portfolio and ranks #5064 among its holdings.

62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Arax Advisory Partners held 100 shares of Anixa Biosciences worth $280 as of Q2 2026.
  • Anixa Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5064 holding.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.